{"id":1389,"date":"2025-10-15T09:39:13","date_gmt":"2025-10-15T09:39:13","guid":{"rendered":"https:\/\/medi-pharm.sk\/prispevok-22-obr"},"modified":"2025-11-23T15:28:21","modified_gmt":"2025-11-23T15:28:21","slug":"prispevok-22-obr","status":"publish","type":"post","link":"https:\/\/medi-pharm.sk\/sk\/prispevok-22-obr","title":{"rendered":"Strat\u00e9gie formul\u00e1cie a stability pre nimodip\u00edn: od in\u017einierstva \u010dast\u00edc po v\u00fdrobu pod\u013ea SVP"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"1389\" class=\"elementor elementor-1389 elementor-766\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-306d09f2 e-con-full e-flex e-con e-parent\" data-id=\"306d09f2\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-222f41cd elementor-widget elementor-widget-spacer\" data-id=\"222f41cd\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-8895ae9 e-flex e-con-boxed e-con e-child\" data-id=\"8895ae9\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-7ae4e065 elementor-widget elementor-widget-theme-post-title elementor-page-title elementor-widget-heading\" data-id=\"7ae4e065\" data-element_type=\"widget\" data-widget_type=\"theme-post-title.default\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Strat\u00e9gie formul\u00e1cie a stability pre nimodip\u00edn: od in\u017einierstva \u010dast\u00edc po v\u00fdrobu pod\u013ea SVP<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-74a268b7 elementor-widget elementor-widget-text-editor\" data-id=\"74a268b7\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p class=\"s5\"><span class=\"s4\">Nimodip\u00edn je dihydropyrid\u00ednov\u00fd blok\u00e1tor v\u00e1pnikov\u00fdch<\/span><span class=\"s4\"> kan\u00e1lov s v\u00fdraznou cerebrovaskul\u00e1rnou selektivitou, klinicky pou\u017e\u00edvan\u00fd na ochranu mozgu pred ischemick\u00fdm po\u0161koden\u00edm prostredn\u00edctvom preferen\u010dn\u00e9ho uvo\u013enenia hladk\u00e9ho svalstva mozgov\u00fdch art\u00e9ri\u00ed pri obmedzen\u00ed syst\u00e9movej hypotenzie. Jeho prim\u00e1rnou indik\u00e1ciou je prevencia a lie\u010dba neurologick\u00fdch deficitov po aneuryzmatickom subarachnoid\u00e1lnom <\/span><span class=\"s4\">krv\u00e1can\u00ed<\/span><span class=\"s4\"> (SAH), kde nimodip\u00edn zni\u017euje riziko oneskoren\u00e9ho cerebr\u00e1lneho vazospazmu a s\u00favisiacich zl\u00fdch neurologick\u00fdch v\u00fdsledkov. Klinick\u00e9 d\u00f4kazy preukazuj\u00fa klinicky v\u00fdznamn\u00e9 zn\u00ed\u017eenie z\u00e1va\u017en\u00fdch neurologick\u00fdch deficitov a \u00famrtnosti u popul\u00e1ci\u00ed s SAH, ak sa nimodip\u00edn pod\u00e1va pod\u013ea usmernen\u00ed<\/span><span class=\"s4\"> odpor\u00fa\u010dan\u00fdch re\u017eimov.<\/span><\/p><p class=\"s5\"><span class=\"s4\">Z farmaceutick\u00e9ho h\u013eadiska predstavuje nimodip\u00edn v\u00fdzvy vo formul\u00e1cii a stabilite. Akt\u00edvna l\u00e1tka je vysoko lipofiln\u00e1, slabo rozpustn\u00e1 vo vode<\/span><span class=\"s4\"> a fotolabiln\u00e1, \u010do rob\u00ed kontrolu kry\u0161talickej formy, distrib\u00facie ve\u013ekosti \u010dast\u00edc a spr\u00e1vania rozp\u00fa\u0161\u0165ania <\/span><span class=\"s4\">kritickou<\/span><span class=\"s4\"> pre konzistentn\u00fa biologick\u00fa dostupnos\u0165. V\u00fdroba a formul\u00e1cia preto vy\u017eaduj\u00fa pr\u00edsne environment\u00e1lne a procesn\u00e9 kontroly, opatrenia na ochranu pred svetlom<\/span><span class=\"s4\"> a validovan\u00e9 met\u00f3dy na zabezpe\u010denie uniformity a reprodukovate\u013en\u00fdch profilov rozp\u00fa\u0161\u0165ania naprie\u010d \u0161ar\u017eami. Rizik\u00e1 stability zah\u0155\u0148aj\u00fa fotodegrad\u00e1ciu a polymorfn\u00e9 zmeny s\u00favisiace s rozp\u00fa\u0161\u0165adlami<\/span><span class=\"s4\">, ktor\u00e9 musia by\u0165 <\/span><span class=\"s4\">charakterizovan\u00e9<\/span><span class=\"s4\"> \u0161t\u00fadiami n\u00fatenej<\/span><span class=\"s4\"> degrad\u00e1cie a monitorovan\u00e9 v \u0161trukt\u00farovanom programe stability <\/span><span class=\"s4\">.<\/span><span class=\"s4\"><\/span><\/p><p class=\"s5\"><span class=\"s4\">Formula\u010dn\u00e9 strat\u00e9gie na rie\u0161enie t\u00fdchto v\u00fdziev zah\u0155\u0148aj\u00fa nosi\u010de na b\u00e1ze lipidov<\/span><span class=\"s4\">, <\/span><span class=\"s4\">solubiliza\u010dn\u00e9<\/span><span class=\"s4\"> pomocn\u00e9 l\u00e1tky, tuh\u00e9 disperzie a pokro\u010dil\u00e9 syst\u00e9my pod\u00e1vania (nano\u010dastice, mikroemulzie, <\/span><span class=\"s4\">lyofilizovan\u00e9<\/span><span class=\"s4\"> formy). V\u00fdber pr\u00edstupu by mal by\u0165 riaden\u00fd cie\u013eov\u00fdm profilom produktu a \u00favahami CMC, s d\u00f4razom na udr\u017eanie kry\u0161talickej integrity, <\/span><span class=\"s4\">optimaliz\u00e1ciu<\/span><span class=\"s4\"> rozp\u00fa\u0161\u0165ania a <\/span><span class=\"s4\">minimaliz\u00e1ciu<\/span><span class=\"s4\"> variability v klinickom v\u00fdkone. Analytick\u00e1 kontrola by mala zah\u0155\u0148a\u0165 identitu, stanovenie, pr\u00edbuzn\u00e9 l\u00e1tky, fotostabilitu, rozp\u00fa\u0161\u0165anie a polymorfizmus, podporovan\u00e9 validovan\u00fdmi analytick\u00fdmi postupmi a vhodn\u00fdmi medziopera\u010dn\u00fdmi<\/span><span class=\"s4\"> kontrolami.<\/span><\/p><p class=\"s7\"><span class=\"s6\">MediPharm<\/span><span class=\"s6\"> perspekt\u00edva<\/span><\/p><p class=\"s5\"><span class=\"s4\">MediPharm<\/span><span class=\"s4\"> pova\u017euje nimodip\u00edn za modelov\u00fa zl\u00fa\u010deninu na rozhran\u00ed komplexnej formula\u010dnej vedy a prec\u00edznej v\u00fdroby pod\u013ea SVP. Spolo\u010dnos\u0165 uplat\u0148uje cielen\u00fd n\u00e1vrh procesu, manipul\u00e1ciu chr\u00e1nen\u00fa pred svetlom<\/span><span class=\"s4\">, kontrolu rozp\u00fa\u0161\u0165adiel a in\u017einierstvo \u010dast\u00edc na udr\u017eanie kvality produktu. <\/span><span class=\"s4\">Mo\u017enosti spolo\u010dnosti MediPharm<\/span><span class=\"s4\"> zah\u0155\u0148aj\u00fa v\u00fdvoj formul\u00e1ci\u00ed (vr\u00e1tane pr\u00edstupov na b\u00e1ze lipidov a tuh\u00fdch<\/span><span class=\"s4\"> disperzi\u00ed), <\/span><span class=\"s4\">lyofiliz\u00e1ciu<\/span><span class=\"s4\">, v\u00fdrobu pod\u013ea SVP s balen\u00edm chr\u00e1nen\u00fdm pred svetlom<\/span><span class=\"s4\"> a komplexn\u00fa dokument\u00e1ciu CMC zah\u0155\u0148aj\u00facu validovan\u00e9 analytick\u00e9 met\u00f3dy, \u00fadaje o n\u00fatenej<\/span><span class=\"s4\"> degrad\u00e1cii, s\u00fabory \u00fadajov o stabilite a moduly pripraven\u00e9 na regula\u010dn\u00e9 podanie<\/span><span class=\"s4\"> vhodn\u00e9 pre podania v E\u00da.<\/span><\/p><p class=\"s3\"><strong><span class=\"s8\">Zdroje:<\/span><\/strong><\/p><pre class=\"s3\"><em><span class=\"s8\">Balaev<\/span><span class=\"s8\">, A.N., Osipov, V.N. a Fedorov, V.E. (2012) <\/span><span class=\"s9\">\u201e<\/span><span class=\"s8\">V\u00fdvoj technol\u00f3gie v\u00fdroby nimodip\u00ednu<\/span><span class=\"s9\">\u201c<\/span><span class=\"s8\">, Pharmaceutical Chemistry Journal, 46(5), s. 285-<\/span><span class=\"s8\">287. doi:10.1007\/s11094-012-0780-6.<\/span><\/em><br><em><span class=\"s8\">Das, J.M. (2024) Nimodip\u00edn, <\/span><span class=\"s8\">StatPearls<\/span><span class=\"s8\"> [Internet]. <br>Dostupn\u00e9 na: <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK534870\/\">https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK534870\/<\/a><\/span><\/em><\/pre>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-1640ec13 elementor-widget elementor-widget-spacer\" data-id=\"1640ec13\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5422b928 elementor-widget elementor-widget-post-info\" data-id=\"5422b928\" data-element_type=\"widget\" data-widget_type=\"post-info.default\">\n\t\t\t\t\t\t\t<ul class=\"elementor-inline-items elementor-icon-list-items elementor-post-info\">\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item elementor-repeater-item-947b1e1 elementor-inline-item\" itemprop=\"datePublished\">\n\t\t\t\t\t\t<a href=\"https:\/\/medi-pharm.sk\/sk\/2025\/10\/15\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-calendar\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M12 192h424c6.6 0 12 5.4 12 12v260c0 26.5-21.5 48-48 48H48c-26.5 0-48-21.5-48-48V204c0-6.6 5.4-12 12-12zm436-44v-36c0-26.5-21.5-48-48-48h-48V12c0-6.6-5.4-12-12-12h-40c-6.6 0-12 5.4-12 12v52H160V12c0-6.6-5.4-12-12-12h-40c-6.6 0-12 5.4-12 12v52H48C21.5 64 0 85.5 0 112v36c0 6.6 5.4 12 12 12h424c6.6 0 12-5.4 12-12z\"><\/path><\/svg>\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text elementor-post-info__item elementor-post-info__item--type-date\">\n\t\t\t\t\t\t\t\t\t\t<time>15 okt\u00f3bra, 2025<\/time>\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t<\/li>\n\t\t\t\t<li class=\"elementor-icon-list-item elementor-repeater-item-f958ce5 elementor-inline-item\">\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-far-clock\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M256 8C119 8 8 119 8 256s111 248 248 248 248-111 248-248S393 8 256 8zm0 448c-110.5 0-200-89.5-200-200S145.5 56 256 56s200 89.5 200 200-89.5 200-200 200zm61.8-104.4l-84.9-61.7c-3.1-2.3-4.9-5.9-4.9-9.7V116c0-6.6 5.4-12 12-12h32c6.6 0 12 5.4 12 12v141.7l66.8 48.6c5.4 3.9 6.5 11.4 2.6 16.8L334.6 349c-3.9 5.3-11.4 6.5-16.8 2.6z\"><\/path><\/svg>\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text elementor-post-info__item elementor-post-info__item--type-time\">\n\t\t\t\t\t\t\t\t\t\t<time>9:39 am<\/time>\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t<\/ul>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Nimodip\u00edn je dihydropyrid\u00ednov\u00fd blok\u00e1tor v\u00e1pnikov\u00fdch kan\u00e1lov s v\u00fdraznou cerebrovaskul\u00e1rnou selektivitou, klinicky pou\u017e\u00edvan\u00fd na ochranu mozgu pred ischemick\u00fdm po\u0161koden\u00edm prostredn\u00edctvom preferen\u010dn\u00e9ho uvo\u013enenia hladk\u00e9ho svalstva mozgov\u00fdch art\u00e9ri\u00ed pri obmedzen\u00ed syst\u00e9movej hypotenzie. Jeho prim\u00e1rnou indik\u00e1ciou je prevencia a lie\u010dba neurologick\u00fdch deficitov po aneuryzmatickom subarachnoid\u00e1lnom krv\u00e1can\u00ed (SAH), kde nimodip\u00edn zni\u017euje riziko oneskoren\u00e9ho cerebr\u00e1lneho vazospazmu a s\u00favisiacich zl\u00fdch neurologick\u00fdch v\u00fdsledkov. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1481,"comment_status":"closed","ping_status":"open","sticky":false,"template":"elementor_header_footer","format":"standard","meta":{"footnotes":""},"categories":[15],"tags":[],"class_list":["post-1389","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized-sk"],"_links":{"self":[{"href":"https:\/\/medi-pharm.sk\/sk\/wp-json\/wp\/v2\/posts\/1389","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medi-pharm.sk\/sk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medi-pharm.sk\/sk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medi-pharm.sk\/sk\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/medi-pharm.sk\/sk\/wp-json\/wp\/v2\/comments?post=1389"}],"version-history":[{"count":4,"href":"https:\/\/medi-pharm.sk\/sk\/wp-json\/wp\/v2\/posts\/1389\/revisions"}],"predecessor-version":[{"id":1584,"href":"https:\/\/medi-pharm.sk\/sk\/wp-json\/wp\/v2\/posts\/1389\/revisions\/1584"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medi-pharm.sk\/sk\/wp-json\/wp\/v2\/media\/1481"}],"wp:attachment":[{"href":"https:\/\/medi-pharm.sk\/sk\/wp-json\/wp\/v2\/media?parent=1389"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medi-pharm.sk\/sk\/wp-json\/wp\/v2\/categories?post=1389"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medi-pharm.sk\/sk\/wp-json\/wp\/v2\/tags?post=1389"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}